Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

SHA:688578 Revenue

Shanghai Allist Pharmaceuticals had revenue of 1.36B CNY in the quarter ending September 30, 2025, with 42.03% growth. This brings the company's revenue in the last twelve months to 4.76B, up 48.49% year-over-year. In the year 2024, Shanghai Allist Pharmaceuticals had annual revenue of 3.56B with 76.29% growth.

• Revenue (ttm): 4.76B
• Revenue Growth: +48.49%
• P/S Ratio: 9.66
• Revenue / Employee: 3.36M
• Employees: 1,417
• Market Cap: 45.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.56B	1.54B	76.29%
Dec 31, 2023	2.02B	1.23B	155.14%
Dec 31, 2022	791.00M	260.91M	49.22%
Dec 31, 2021	530.09M	529.53M	94,409.97%
Dec 31, 2020	560.89K	-68.84K	-10.93%